Research location
Lake Jackson
Texas, United States
Advertisement
Research activity in Lake Jackson
Texas, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 61 trials and 61 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Lake Jackson
61 linked trials · page 1 of 2Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityNCT07037433 · 2025-07-25 · 1 site observation
RECRUITING
Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)NCT05103332 · 2021-11-05 · 1 site observation
COMPLETED
Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With HypertensionNCT01692301 · 2012-12-01 · 1 site observation
COMPLETED
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)NCT01601704 · 2012-06-01 · 1 site observation
TERMINATED
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive DisorderNCT01370733 · 2012-05-01 · 1 site observation
COMPLETED
8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With HypertensionNCT01570686 · 2012-04-01 · 1 site observation
COMPLETED
An Open Label Study for Participants With Rheumatoid ArthritisNCT01215942 · 2011-06-01 · 1 site observation
TERMINATED
Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and DiabetesNCT01368536 · 2011-05-01 · 1 site observation
TERMINATED
A Rheumatoid Arthritis Study in ParticipantsNCT01202760 · 2011-01-01 · 1 site observation
COMPLETED
Safety and Efficacy of RX-10100 to Treat Major Depressive DisorderNCT01273376 · 2010-12-01 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes MellitusNCT01191320 · 2010-10-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderNCT01179516 · 2010-08-01 · 1 site observation
COMPLETED
A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderNCT01152554 · 2010-06-01 · 1 site observation
COMPLETED
A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful SymptomsNCT01000805 · 2009-11-01 · 1 site observation
COMPLETED
SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive DisorderNCT00985725 · 2009-10-29 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01009463 · 2009-09-25 · 1 site observation
COMPLETED
A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin GlargineNCT00976391 · 2009-09-01 · 1 site observation
COMPLETED
An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's DiseaseNCT00939783 · 2009-09-01 · 1 site observation
TERMINATED
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic PatientsNCT00900146 · 2009-04-01 · 1 site observation
TERMINATED
A Study in the Treatment of Children and Adolescents With Major Depressive DisorderNCT00849693 · 2009-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Albiglutide in Treatment of Type 2 DiabetesNCT00838903 · 2009-02-01 · 1 site observation
COMPLETED
A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 DiabetesNCT00838916 · 2009-02-01 · 1 site observation
COMPLETED
A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 DiabetesNCT00839527 · 2009-02-01 · 1 site observation
COMPLETED
Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic PainNCT00838799 · 2009-02-01 · 1 site observation
COMPLETED
A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's DiseaseNCT00838110 · 2009-02-01 · 1 site observation
COMPLETED
Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care SettingNCT01013948 · 2009-02-01 · 1 site observation
COMPLETED
Safety and Efficacy of Albiglutide in Type 2 DiabetesNCT00849056 · 2009-01-01 · 1 site observation
COMPLETED
Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 DiabetesNCT00821977 · 2008-11-01 · 1 site observation
COMPLETED
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionNCT00649389 · 2008-05-01 · 1 site observation
COMPLETED
A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe DepressionNCT00666757 · 2008-05-01 · 1 site observation
COMPLETED
Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive DisorderNCT00672958 · 2008-04-01 · 1 site observation
COMPLETED
Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential HypertensionNCT00591266 · 2007-10-01 · 1 site observation
COMPLETED
Efficacy and Safety of LCZ696A in Patients With Essential HypertensionNCT00549770 · 2007-09-01 · 1 site observation
COMPLETED
A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) PatientsNCT00536471 · 2007-09-01 · 1 site observation
COMPLETED
Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive DisorderNCT00529789 · 2007-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential HypertensionNCT00696241 · 2007-06-01 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive DisorderNCT00467402 · 2007-04-01 · 1 site observation
COMPLETED
A Efficacy Study of PRX-00023 in Patients With Major Depressive DisorderNCT00448292 · 2007-03-01 · 1 site observation
COMPLETED
A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And SafetyNCT00375401 · 2006-10-01 · 1 site observation
TERMINATED
Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of HypertensionNCT00281580 · 2006-04-01 · 1 site observation
COMPLETED
Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917NCT00290940 · 2006-01-01 · 1 site observation
COMPLETED
EEG Biomarkers for Predicting Response to Antidepressant TherapyNCT00289523 · 2006-01-01 · 1 site observation
COMPLETED
Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive DisorderNCT00278941 · 2005-12-01 · 1 site observation
COMPLETED
Study of BMS-562086 in the Treatment of Outpatients With Major Depressive DisorderNCT00135421 · 2005-11-01 · 1 site observation
COMPLETED
Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe HypertensionNCT00185133 · 2005-05-01 · 1 site observation
COMPLETED
Study Of GW679769 In Major Depressive DisorderNCT00102492 · 2004-10-01 · 1 site observation
COMPLETED
A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive DisorderNCT00191061 · 2004-10-01 · 1 site observation
COMPLETED
Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe HypertensionNCT00095394 · 2004-09-01 · 1 site observation
COMPLETED
A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major DepressionNCT00128479 · 2004-09-01 · 1 site observation
COMPLETED
Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression EpisodeNCT00080314 · 2004-01-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.